Foundation models for genomics and proteomics are powerful - but they're also 650 million to 2.5 billion parameters. Running them means cloud GPUs, data transfer agreements, and compute budgets that compete with wet lab time.
We build models that are orders of magnitude smaller while matching or approaching the accuracy of full-size foundation models. They run on a workstation. On a laptop. Offline. Your sequences never leave your network.
Generates biologically valid protein sequences with full amino acid diversity. All 20 standard amino acids represented. No mode collapse.
Trained on minimal data. Evaluated against significantly larger established models using the same pipeline. Outperforms on multiple genomic tasks.
Validated on real biological features. The model captures genomic structure, not just statistics. Detailed benchmarks available under NDA.
Workstation GPU, M-series MacBook, even embedded devices. No cloud compute budget. No data transfer agreements.
No API calls. No cloud provider sees your sequences. Run air-gapped if your institution requires it.
Train a specialist on your proprietary sequences in minutes. CYP variants, binding sites, expression patterns. Tiny adapter, your data.
Drug interaction, clinical trial screening, patient stratification - all from one base model. Switch in milliseconds.
Provide pre-trained models. Protein and DNA foundation models, ready to use. Fine-tune on your data or use as-is for embeddings, classification, generation.
Train on your data. We train custom specialists on your proprietary sequences. You get a compact model file. We never see your raw data - only the trained adapter.
Embed in your pipeline. Our models export to PyTorch, CoreML, ONNX. Drop into your existing bioinformatics pipeline. No new infrastructure.
Research collaboration. Joint publications. Your domain expertise, our compression architecture. We've published in IEEE and collaborate with researchers across genomics, proteomics, and computational biology.
We work with research labs, pharma R&D, and biotech companies who need AI that respects their data boundaries.